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Corneal integrity and transparency are indispensable for good vision. Cornea homeostasis is entirely depen-
dent upon corneal stem cells, which are required for complex wound-healing processes that restore corneal 
integrity following epithelial damage. Here, we found that leucine-rich repeats and immunoglobulin-like 
domains 1 (LRIG1) is highly expressed in the human holoclone-type corneal epithelial stem cell population 
and sporadically expressed in the basal cells of ocular-surface epithelium. In murine models, LRIG1 regulated 
corneal epithelial cell fate during wound repair. Deletion of Lrig1 resulted in impaired stem cell recruitment 
following injury and promoted a cell-fate switch from transparent epithelium to keratinized skin-like epi-
dermis, which led to corneal blindness. In addition, we determined that LRIG1 is a negative regulator of the 
STAT3-dependent inflammatory pathway. Inhibition of STAT3 in corneas of Lrig1–/– mice rescued pathologi-
cal phenotypes and prevented corneal opacity. Additionally, transgenic mice that expressed a constitutively 
active form of STAT3 in the corneal epithelium had abnormal features, including corneal plaques and neovas-
cularization similar to that found in Lrig1–/– mice. Bone marrow chimera experiments indicated that LRIG1 
also coordinates the function of bone marrow–derived inflammatory cells. Together, our data indicate that 
LRIG1 orchestrates corneal-tissue transparency and cell fate during repair, and identify LRIG1 as a key regula-
tor of tissue homeostasis.
Introduction
In mammals, most external information is accumulated through 
visual systems, and integrity of the cornea is well known to be 
indispensable for good vision (1). During evolution, nature has 
found a way to develop a well-ordered visual system to main-
tain corneal tissue transparency and homeostasis. The cornea 
is a unique avascular and transparent epithelial tissue that har-
bors stem cells that control homeostasis and tissue regeneration 
after injury (2, 3). However, the homeostatic turnover of corneal 
epithelial tissue can become disrupted depending on the sever-
ity of damage to the corneal epithelium, resulting in collateral 
chronic inflammation and impaired tissue repair (4, 5). These 
inflammation- associated processes reportedly interfere with cor-
neal transparency and the cornea’s barrier function (6).
It is well known that stem cells work to maintain the self renewal 
and repair of tissues and organs (7, 8). Under normal conditions, 
the corneal epithelial tissue accommodates the homeostatic turn-
over of corneal stem cells, which is essential for postinjury tissue 
regeneration. Previous studies have reported that corneal epithelial 
stem cells reside in the basal layer of the limbal zone of the periph-
eral cornea (9, 10). The corneal epithelial stem cell system is one of 
the most clearly defined systems and is therefore an ideal model for 
investigating the role of regulatory molecules associated with stem 
cell tissue repair (2, 3). However, the molecular interplay between 
corneal epithelial stem cells and other players with critical roles in 
the regulation of tissue repair has yet to be elucidated.
Barrandon et al. previously reported the existence of 3 types 
of epidermal keratinocytes with different self-renewal capacities 
(11). Similar behavior has subsequently been reported for corneal 
keratinocytes (12). Holoclones (stem cells) have the highest repro-
ductive capacity, while in paraclones (transient amplifying cells), 
terminal differentiation is observed within a few generations. 
However, the molecular mechanism and gene expression profile 
of holoclone-type stem cells are entirely unknown.
Leucine-rich repeats and immunoglobulin-like domains 1 
(LRIG1) is a transmembrane glycoprotein recently reported as 
a potential master regulator of epidermal and intestinal epithe-
lial stem cells (13–17). However, there are no reports to date that 
address the tissue-specific function of LRIG1 in the cornea. The 
findings of this present study demonstrate that LRIG1 was highly 
expressed in the holoclone-type corneal epithelial stem cells 
and that it was essential for the cell-fate maintenance of corneal 
epithelium during tissue repair. Loss of Lrig1 impaired wound-
induced corneal stem/progenitor cell replacement and resulted in 
a cell-fate change from corneal to keratinized epithelium. Intrigu-
ingly, we found that LRIG1 controlled the corneal cell fate during 
repair by negatively regulating the Stat3-dependent inflamma-
tory pathway. Moreover, corneal cell fate during repair was not 
only maintained by corneal epithelial stem/progenitor cells, but 
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also by BM-derived inflammatory cells, whose functions are well-
regulated by the LRIG1/STAT3 inflammatory pathway. Thus, 
the findings of this present study provide new insights into the 
underlying homeostatic regulation of corneal keratinocyte stem/
progenitor cells by LRIG1.
Results
Gene expression profile of holoclone-type corneal keratinocyte stem 
cells. In order to gain insight into the mechanisms responsible 
for the homeostasis within epithelial stem cells, we performed 
gene expression profiling of holoclone-type and paraclone-type 
human corneal keratinocytes. This led to the identification of 15 
genes that were upregulated at least 5-fold in holoclone-type cor-
neal epithelial stem cells (Supplemental Tables 1 and 2; supple-
mental material available online with this article; doi:10.1172/
JCI71488DS1). We next examined the expression pattern of these 
genes using immunohistochemistry and identified Lrig1 for fur-
ther investigation, because LRIG1 was specifically expressed in 
human limbal basal cells and rarely expressed in the differenti-
ated central corneal epithelium (Figure 1A). In contrast, in mouse 
eyes, LRIG1 was only found to be sporadically expressed in the 
basal cells of the ocular surface epithelium (cornea, limbus, and 
conjunctiva), and immunostaining patterns suggested a cluster 
(patch) organization (Figure 1B), indicating a strong relationship 
with epithelial stem/progenitor cell–related molecules (18).
Loss of Lrig1 results in a cell-fate change from corneal to keratinized epi-
thelium. To clarify the biological roles of Lrig1 in the cornea, we gen-
erated Lrig1-deficient mice according to our previous protocol (13) 
and then analyzed their phenotype in detail. During the develop-
mental stage (E15–P10), there were no abnormal phenotypes in the 
cornea (data not shown). At 3 months of age, neither Lrig1 WT nor 
KO mouse corneas elicited abnormal phenotypes, as observed 
both macroscopically and histologically (Figure 2A). However, 
corneal epithelial stratification, the number of conjunctival 
goblet cells, and BrdU-labeled cell ratios (in vitro) tended to be 
slightly higher in the KO specimens, thus suggesting that Lrig1 
plays a role even in steady-state homeostasis (Supplemental 
Figure 1). After a latency period of 6 months, Lrig1-KO corneas 
gradually formed corneal plaques with massive neovascular-
ization and intense infiltration of inflammatory cells. Finally, 
approximately 70% of the Lrig1-KO mice developed abnormal 
corneal phenotypes within 24 months (Figure 2B). Histologi-
cal examination revealed extensive thickening and pathologi-
cal keratinization of the corneal epithelium, with inflamma-
tion of the underlying corneal stroma (Figure 2A).
To determine the biological characteristics of the corneal 
epithelial cells, we performed immunohistochemistry for 
cornea-specific keratin 12 and epidermis-specific loricrin 
(Figure 3A). While the epithelia of the WT corneas (3, 8, and 
12 months) specifically expressed keratin 12, that of the Lrig1-
KO corneas (3, 8, and 12 months) had gradually lost keratin 12 
(Supplemental Figure 2) and gained loricrin expression. These 
changes were also associated with increased proliferation, as deter-
mined by BrdU labeling. This suggests that loss of Lrig1 results in 
a cell-fate change from corneal to keratinized epithelium, which 
leads to the thickening of the epithelium.
Inflammation is a known clinical feature of keratinization-
associated blindness, and tissue-intrinsic inflammatory responses 
recruit hematopoietic cells, as they drive epithelial hyperprolifera-
tion via a reciprocal signaling loop (19, 20). Characterization of 
the inflammatory infiltrates in remodeling tissues of Lrig1-KO 
corneal stroma (12 months) showed pronounced recruitment of 
CD31-, F4/80-, GR1-, and CD3-positive cells (Figure 3B), while 
these were completely absent in the normal WT corneal stroma 
(12 months). This implies that the loss of Lrig1 results in the inten-
sive infiltration of BM-derived inflammatory cells.
Loss of Lrig1 impairs wound-induced corneal stem cell turnover. Corneal 
homeostasis is maintained by stem cells, which are responsible for 
physiological cell turnover and the wound-healing response (2, 3). 
We hypothesize that the cell-fate switch observed in the Lrig1-
deficient corneal epithelium is a consequence of an abnormal 
tissue repair process following injury. To investigate this theory, 
we performed mechanical corneal-epithelial debridement (2 mm) 
under a microscope. After wounding the cornea once per week 
for 3 weeks, all of the KO corneas (3 months) developed intensive 
inflammation and subsequent corneal opacity, in contrast with 
the WT corneas (3 months) with normal phenotypes (Figure 4A). 
This strongly implies that the cell-fate switch of the Lrig1-KO cor-
nea is initiated by wound stimulation. We next examined the cor-
neal wound repair process, kinetically, until 7 days after wounding. 
Slit-lamp examination using fluorescein staining clearly revealed 
Figure 1
Expression of LRIG1 in the ocular surface epithelium (corneal, lim-
bal, and conjunctival). (A and B) Slit-lamp photographs of a human 
eye and a mouse eye. Immunohistochemistry for LRIG1 (green, 
arrows) in human (10 years) and mouse (3 months) ocular surface 
epithelium. Nuclei are counterstained with PI (red). The dashed line 
indicates the limbal area. C, central cornea; L, limbal cornea, Cj, 
conjunctiva. Scale bars: 100 μm.
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delayed and incomplete wound healing in the absence of Lrig1 
(Figure 4B). This finding suggests that the loss of Lrig1 impairs 
the recruitment of stem/progenitor cells after wounding.
Loss of Lrig1 causes the proinflammatory state in the cornea. Once a 
tissue senses invading insults, various types of innate resistance 
are initiated to limit the tissue damage. Inflammation is gener-
ally associated with altered cytokine and chemokine expression, 
and proinflammatory mediators are increased and then decayed 
by positive and negative feedback mechanisms (20). Surpris-
ingly, Lrig1-KO corneas (2–3 months) prior to wounding tended 
to display elevated levels of inflammatory cytokines, even in the 
absence of gross morphological changes (Figure 5). After injury, 
the levels of cytokines regulating innate lymphoid cells (ILC) and 
T lymphocyte subsets, such as TH1, TH2, and TH17, tended to 
be higher in the KO corneas as compared with the WT corneas 
(Figure 5). These findings suggest that the loss of Lrig1 confers 
a proinflammatory state in the cornea, thus accelerating the 
wound-induced inflammatory responses.
Lrig1 operates as a negative regulator of the Stat3-dependent inflamma-
tory pathway. Chronic inflammation reportedly stimulates ErbB, 
Wnt, and Notch signaling proteins (14–17, 19–21). Analysis of 
Lrig1-KO and WT corneas (3 and 12 months) showed no apparent 
difference in these signaling pathways (Supplemental Figure 3). 
A subset of cytokines are reportedly involved in the progression 
and resolution of tissue inflammation signals via the JAK/STAT 
pathway (22–27). Examination of Lrig1 WT and Lrig1-KO corneas 
(3 months) showed elevated expression levels of Stat3 in the KO tis-
sues (Figure 6A). Moreover, Stat3 luciferase reporter assays, using 
both mouse conjunctival fibroblasts and keratinocytes, showed 
elevated responsiveness to IL-6 upon loss of Lrig1 (Figure 6B). This 
implies that Lrig1 affects, directly or indirectly, transcriptional acti-
vation downstream of Stat3. Next, we analyzed the expression of 
Stat3 and phosphorylated Stat3 (pStat3, activated) in Lrig1 WT 
and Lrig1-KO corneas (3 months). Under normal conditions, Stat3 
was detected in both WT and KO corneal epithelium, yet we did 
not detect pStat3 (Figure 6C). Three weeks after single wound 
Figure 2
The development of corneal plaques in 
Lrig1-deficient mice. (A) Slit-lamp photo-
graphs of Lrig1 WT (3 months), Lrig1-KO 
(3 months), and KO (12 months) mouse 
corneas, and their histological appearances 
with H&E staining. Scale bars: 100 μm. (B) 
Percentage of mouse eyes with corneal phe-
notype under natural observation (n = 30). 
Slit-lamp photographs of Lrig1 WT/KO (3, 8, 
and 12 months) mouse corneas.
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stimulation, nuclear pStat3 was readily detected only in the Lrig1-
KO’s corneal epithelium and stroma, suggesting that Lrig1 nega-
tively regulated the Stat3 activation (Figure 6C). SOCS proteins 
are critical negative feedback regulators of the cytokine/JAK/STAT 
pathway and represent early processors of STAT signaling (28–30). 
The expression of gp130 was unchanged in the WT and KO corneas 
(3 months), but RNA expression of SOCS3 tended to be elevated 
in the Lrig1-KO tissues, both during steady-state homeostasis and 
upon wounding, in line with the increased STAT signaling (Fig-
ure 6D). In striking contrast, the expression of JAK1/2 tended to 
be downregulated in Lrig1-KO corneas with wound stimulation 
(Figure 6D). This strongly implies that Lrig1 operates as a negative 
regulator of the Stat3-dependent inflammatory pathway.
Activation of Stat3 represents the pathological phenotypes evident in 
Lrig1-KO corneas. In order to reveal whether epithelial activation 
of Stat3 sufficiently mimics the loss-in-function observed in the 
Lrig1-KO cornea, we examined the tissues from a Tg mouse model 
(6 months); these tissues express constitutively active Stat3 (K5 Stat3 
Tg) in the basal layer of the epithelium (26). It is noteworthy that 
the Tg mice developed corneal plaques with neovascularization 
that, phenotypically, closely resembled that in the Lrig1-KO cornea 
(Figure 7A). Histological examination revealed pathological kera-
tinization of the corneal epithelium, with extensive remodeling of 
the underlying stroma showing F4/80+ve and CD3+ve inflammatory 
infiltrates (Figure 7, B and C). This finding is also associated with 
cell-fate switching from keratin 12 to loricrin expression (Figure 
7C), and demonstrates that activation of Stat3 recapitulates the 
pathological phenotypes evident in Lrig1-KO corneas.
This prompted us to investigate whether Stat3 blocking would 
inhibit the pathological phenotypes found in Lrig1-KO corneas. 
After corneal wounding, a Stat3 inhibitor, STA21 (31, 32), was topi-
cally applied on the corneal surface 4 times a day. Seven days after 
wounding (7 d), WT and Lrig1-KO corneas (3 months) that received 
STA21 exhibited transparent corneas without inflammation, where-
as Lrig1-KO corneas without STA21 exhibited corneal opacity (Fig-
ure 7D). Seven days after a second wound (14 d), WT corneas with-
out STA21 still maintained transparency; however, Lrig1-KO corneas 
without STA21 exhibited corneal plaques with intensive inflamma-
tion and sometimes hypopyon (Figure 7, E and F). Together, these 
findings demonstrate that blocking Stat3 rescued the incidence of 
pathological phenotypes observed in the Lrig1-KO corneas.
Lrig1 coordinates BM-derived inflammatory cells. The intensive infil-
tration of inflammatory cells into the Lrig1-KO cornea suggests the 
possibility that Lrig1 may play a critical role in stem cell–related 
Figure 3
Cell-fate switch of the corneal epithelium resulting in the intensive infiltration of BM-derived inflammatory cells in the corneas, caused by 
loss of Lrig1. (A) Immunostaining for keratin 12, loricrin, LRIG1 (green), and BrdU (red) in Lrig1 WT and Lrig1-KO corneas (12 months). 
(B) Immunostaining for hematopoietic cell markers such as CD31, F4/80, GR1, and CD3 (green) in Lrig1 WT and Lrig1-KO corneas (12 months). 
Nuclei are counterstained with PI (red) and DAPI (blue). Scale bars: 100 μm.
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tissue repair in the corneal epithelium. To demonstrate the con-
tribution of BM-derived cells in the role of LRIG1, we performed 
the corneal wound experiment twice (days 0 and 7) in BM chime-
ric mice. Validation of BM reconstitution revealed a successful 
hematopoietic reconstitution of primary and secondary lymphoid 
organs, with myeloid and lymphoid cells in all BM chimeras (Sup-
plemental Figure 4). Before wounding (10 weeks after BM trans-
plantation [BMT]), no mice (WT or KO) showed the abnormal 
corneal phenotypes. Seven days after wounding, WT (donor)→WT 
(recipient) mice, and KO→WT mice showed transparent corneas 
and no abnormal corneal phenotypes, suggesting that only KO-
derived BM cells were not enough to induce the corneal phenotype 
(Figure 8, A–C). As expected, KO→KO mice showed corneal plaque, 
but cell infiltration and inflammation in the WT→KO mice was 
reduced (Figure 8, A and B). KO→KO mice exhibited corneal 
plaque with inflammatory features 21 days after wounding. How-
ever, in WT→KO mice, inflammatory features and the formation 
of corneal plaques were reduced, as observed both macroscopically 
and histologically, suggesting that WT-derived BM cells could res-
cue the corneal pathological phenotypes in Lrig1-KO corneas and 
that both corneal and BM cell abnormalities are needed to trigger 
LRIG1 pathogenesis (Figure 8, C and D). These results imply that 
Lrig1 may coordinate, albeit in part, BM-derived inflammatory cells, 
which are essential for corneal maintenance during wound healing.
Discussion
The results of this study demonstrate that loss of Lrig1 during 
corneal repair resulted in the cell-fate switch from transparent 
Figure 4
Wound-induced corneal stem cell replacement impaired by the loss of Lrig1. (A) Percentage of mouse eyes with corneal phenotype under wound 
stimulations (n = 6). Slit-lamp photographs of Lrig1 WT and Lrig1-KO wounded corneas (3 months old) at each time point (0, 1, and 2 weeks after 
wounding). Fluorescein green staining was used to identify the area of epithelial defect. Corneal inflammation and subsequent corneal opacity 
(arrow). (B) Slit-lamp photographs of Lrig1 WT and Lrig1-KO wounded corneas (3 months old) at each time point (0, 12, 24, 48, 72, 120, and 168 
hours after wounding). Fluorescein green staining was used to identify the area of remaining epithelial defect. *P < 0.01 (n = 4).
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corneal epithelium to keratinized skin-like epidermis, leading to 
corneal blindness. This pathological skin-like epithelium differed 
from the physiological mouse epidermis, as it showed epithelial 
hyperproliferation and invaginations into the underlying corneal 
stroma. A previous report indicated that LRIG1 expression defines 
a distinct multipotent stem cell population in mammalian epider-
mis and normally contributes to the interfollicular epidermis and 
sebaceous glands (15). Our findings show that Lrig1-KO corneas 
with wounding formed corneal plaques with massive neovascular-
ization and intense infiltration of inflammatory cells. However, 
the findings of a previous report from a member of our group 
illustrated that Lrig1-KO mice, with or without minor wound stim-
ulation on the trunk skin, did not develop any epidermal hyperpla-
sia (psoriasiform skin changes), suggesting that more continuous 
wounding might be needed to induce the phenotypes in the areas 
covered with thick hair (13).
In a normal situation, tear film is essential for maintaining the 
stability of ocular surface epithelium; therefore, eyelids, including 
meibomian glands, have a critical role in corneal homeostasis. The 
other findings of a previous report from a member of our group 
demonstrated that Notch1 deficiency results in loss of meibomian 
glands, causing the loss of tear film, and microlesions of the corne-
al epithelium (19). We thus examined the morphology of eyelids in 
Lrig1-KO mice and found that there were no abnormal phenotypes 
in them (data not shown). Further investigation regarding Notch1 
and LRIG1 interaction is needed to clarify this point.
In our observation series, Lrig1-KO corneas gradually formed 
corneal plaques and, finally, approximately 70% of the Lrig1-KO 
mice developed abnormal corneal phenotypes within 24 months. 
Although we breed the mice under specific pathogen–free condi-
tions and we only observed the corneal phenotype in Lrig1-KO 
mice, not in the WT mice, caged mice often receive repeated small 
wounds to the epithelial surface and it seems highly likely that 
these events might precipitate the phenotype in older mice.
One of the most striking findings is that the loss of Lrig1 con-
fers a proinflammatory state in the cornea, and after wound 
stimulation, Lrig1-KO corneas exhibited extensive cellular infil-
tration and inflammation. The cornea is a unique transparent 
epithelial tissue in the body, and nature has found a way to pro-
vide the cornea with an antiinflammatory system that greatly 
reduces the threat of inflammation-induced visual loss (6). 
Tissue-intrinsic inflammatory responses recruit hematopoietic 
cells that amplify the response through their innate receptors, 
triggered by endogenous ligands present in the inflamed tissue. 
Thus, the remodeling of corneal stroma was characterized by the 
existence of blood vessels (neovascularization), infiltration of 
inflammatory cells, morphological changes of collagen fibrils, 
and abnormal corneal keratocytes (Supplemental Figure 5). 
Immunohistochemistry revealed that hematopoietic cell markers 
were distinctly expressed in the remodeling stroma of the Lrig1-
KO corneas, whereas no or limited expression was observed in 
the Lrig1 WT corneas. In view of these findings, it is clear that 
Figure 5
Loss of Lrig1 causes the proinflammatory state in the cornea. Cytokine 
profiles (TNFα, MCP1, IFNγ, TSLP, and IL-5/10/13/17/25/33) of Lrig1 
WT and Lrig1-KO corneas (2–3 months) in the prewound, early wound, 
and chronic wound stage by real-time PCR (n = 4 corneas mixed). 
Numbers show relative mRNA expression.
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LRIG1 modulates the ocular antiinflammatory system and may 
have some role in maintaining corneal transparency.
It has been reported that cell-fate decision depends on the sur-
rounding microenvironment (niche) and that stem cells and 
niche cells exchange specific signals with one another (7, 8). Inter-
estingly, development of corneal plaques in Lrig1-KO mice was 
always accompanied by the remodeling of the corneal stroma. 
The kinetic study revealed that cell-fate changes in the Lrig1-KO 
cornea were preceded by changes within the underlying corneal 
stroma. The loss of Lrig1 in the corneal epithelium resulted first in 
the upregulation of various kinds of cytokines regulating ILC and 
T cell subsets. Subsequently, they recruited inflammation-induc-
ible hematopoietic cells to the cornea, finally leading to the remod-
eling of the corneal stroma. Only after formation of this microen-
vironment did the Lrig1-KO corneal cells undergo the phenotype 
switch. These findings suggest that the microenvironment must 
provide tissue-specific signals that allow corneal epithelial cells to 
change their phenotypes. The mechanism of the cell-fate switch 
Figure 6
Stat3 activation induced by the loss 
of Lrig1. (A) Relative expression of 
Stat3 in Lrig1 WT and Lrig1-KO 
corneas (n = 4 corneas mixed, 
3 months). (B) Stat3 expression 
transcriptionally inhibited by Lrig1. 
Luciferase reporter assay using 
mouse cultured conjunctival fibro-
blast and keratinocytes, with or 
without IL-6 stimulation. *P < 0.01 
(n = 4). (C) Immunohistochemistry 
for Stat3 and pStat3 (green) in 
Lrig1 WT and Lrig1-KO corneas 
(3 months), with or without wound. 
Nuclei are counterstained with PI 
(red). Dashed lines indicate the 
border between epithelium and 
underlying stroma. Scale bar: 
100 μm. (D) Relative expression 
of JAK/STAT-related molecules 
(gp130, SOCS3, and JAK1 and 
JAK2) in Lrig1 WT and Lrig1-KO 
corneas, with or without wound 
(n = 4 corneas mixed, 3 months).
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of the Lrig1-KO cornea after wounding seems to be the result of 
tissue-intrinsic inflammatory responses.
In chronically inflamed murine tissues, several factors, including 
NF-κB, TGF-β1, bone morphogenetic proteins, and Wnt, Notch, 
and ErbB signaling proteins, are upregulated in the context of 
inflammation, thus leading to mesenchymal differentiation and a 
strong inductive signal for stem-cell proliferation (14–17, 19–21). 
In Lrig1-KO corneas, we were unable to confirm any distinction 
in the expression of these factors from those in the WT corneas. 
Various cytokines are involved in the progression and resolution of 
tissue inflammation, and most cytokines utilize the so-called JAK/
STAT pathway (22–27). Therefore, we next focused on the JAK/
STAT pathway as a potential target for further investigations.
STATs are a family of latent cytoplasmic proteins involved in 
transmitting extracellular signals to the nucleus (22–24). Most 
surprisingly, continuous activation of Stat3 resulted in the repro-
duction of pathological phenotypes evident in Lrig1-KO corneas. 
Stat3 reportedly plays a critical role in various biological activities, 
Figure 7
Reproduction of pathological phe-
notypes evident in Lrig1-KO cor-
neas resulting from the activation 
of Stat3. (A and B) Slit-lamp pho-
tographs and histological appear-
ances with H&E staining of control 
and K5 Stat3 Tg mouse corneas 
(6 months). Scale bars: 100 μm. 
(C) Immunohistochemistry for ker-
atin 12, loricrin, F4/80, and CD3 
(green) in control and K5 Stat3 
Tg corneas. Nuclei are counter-
stained with PI (red). Scale bar: 
100 μm. Generation of Lrig1-KO 
corneal phenotypes rescued by 
blocking Stat3. (D) Seven days 
after the first corneal wound (7 d), 
Lrig1 WT and Lrig1-KO corneas 
(3 months) treated with STA21 
were transparent, without inflam-
mation, yet Lrig1-KO corneas 
without STA21 showed corneal 
opacity (arrow). (E) Seven days 
after the second wound (14 d), 
Lrig1 WT corneas without STA21 
still maintained their transparency, 
while Lrig1-KO corneas without 
STA21 exhibited corneal plaques 
with inflammation (arrows). (F) 
Histological appearances of the 
resultant corneas (14 d) with H&E 
staining. Scale bar: 100 μm.
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expressed in them (data not shown). Thus, we presume that Stat3 
inhibitor–based therapy might be effective for treating patients 
with most severe ocular surface diseases.
We demonstrated the interaction between LRIG1 and the Stat3 
molecule, but its precise mechanism has yet to be determined. It has 
been reported that LRIG1 is a negative regulator of EGF and Met 
receptors and that LRIG1-mediated receptor ubiquitination and 
degradation may contribute to the suppression of these receptor 
functions (33–35). In view of these previous findings, it could also 
be possible that LRIG1 regulates the expression of these receptors, 
thereby limiting their activities. From our experiments, we only 
demonstrated that LRIG1, directly or indirectly, regulates Stat3 
activation. Future extensive study is needed to clarify this point.
Tissue-intrinsic inflammatory responses recruit hematopoi-
etic cells, and characterization of the inflammatory infiltrates in 
remodeling Lrig1-KO tissues obviously showed pronounced recruit-
including cell proliferation, survival, and migration. Sano et al. pre-
viously reported that Stat3 is activated in keratinocytes of human 
psoriatic lesions, and Tg mice expressing a constitutively active 
form of Stat3 in keratinocytes developed skin lesions, either spon-
taneously or in response to wounding, that closely resemble human 
psoriasis (26). Itami et al. also reported that loss of Lrig1 resulted 
in psoriasiform epidermal hyperplasia and that LRIG1 expression 
was apparently downregulated in human psoriatic lesions (13). 
Using a mouse model, we clearly demonstrate that activation of 
Stat3 reproduced the pathological phenotypes observed in Lrig1-
KO corneas and abrogation of Stat3 function inhibited the corneal 
phenotype switch, thus suggesting that LRIG1 and Stat3 molecules 
are closely linked with one another, both clinically and biologically. 
In addition, we have performed immunohistochemistry for pStat3 
in pathologically keratinized corneal tissues in patients with severe 
ocular surface disease and have found that pStat3 was sporadically 
Figure 8
The corneal pathological phenotypes in Lrig1-KO mice rescued by WT-derived BM cells. (A–C) Slit-lamp photographs of BM chimera mice 
corneas at each time point (0, 7, and 21 days after wounding, n = 4 or 5). Fluorescein green staining was used to identify the area of remaining 
epithelial defect. (D) Histological appearances with H&E staining of BM chimera mouse corneas. Scale bar: 100 μm.
Downloaded from http://www.jci.org on January 11, 2016.   http://dx.doi.org/10.1172/JCI71488
research article
394 The Journal of Clinical Investigation   http://www.jci.org   Volume 124   Number 1   January 2014
Previous biological findings showed that LRIG1 controls the 
fundamental signal network within the epithelial area (13–17), 
and there are no reports to date that demonstrate the crosstalk 
between the epithelium and the surrounding microenvironment. 
The cellular microenvironment is crucial for the maintenance of 
stem cells as well as for cell-fate decision during tissue repair. BM-
derived cells reportedly stabilize their surrounding tissue micro-
environments by adapting different phenotypes as feed-forward 
mechanisms to maintain tissue homeostasis (36–42). Based on 
the results of our corneal wound experiment using BM chimera 
mice, we hypothesize that LRIG1 might regulate BM-derived cell 
behavior. However, its precise mechanism is a complex organismal 
process and remains to be determined.
Importantly, and based on the findings in the present study, 
ocular inflammation is incompatible with good vision, and cor-
neal cell fate during repair is not only maintained by corneal 
epithelial stem cells, but also by BM-derived inflammatory cells, 
whose functions are well controlled by the Lrig1/Stat3 inflam-
matory pathway (Figure 9). In view of these and previous find-
ings on the function of LRIG1 in epidermal and intestinal stem 
cells (13–17), we theorize that LRIG1 provides a general mecha-
nism to control systemic tissue homeostasis and serves as a target 
for therapeutic exploitation.
ment of CD31-, F4/80-, GR1-, and CD3-positive cells, suggest-
ing that LRIG1 might coordinate BM-derived inflammatory cell 
behavior. In fact, Sano et al. previously showed a dual requirement 
for activated Stat3 in epidermal keratinocytes as well as activated 
T lymphocytes in the skin of Tg mice for development of psoriatic 
lesions, leading to the hypothesis that the changes in Stat3-regulated 
genes in keratinocytes cooperate with activated immunocytes in 
the development of psoriasis (26). BM-derived cells are credited 
with playing a critical role in the resolution of inflammation and 
tissue repair, not just under homeostatic conditions, but also as key 
players in tissue repair during wound healing through the interplay 
with cells bearing stem or progenitor cell properties.
Scientifically, it is extremely important to find the corneal dis-
ease model linked to LRIG1. In fact, we demonstrated the activa-
tion of Stat3 in pathologically keratinized epithelium in severe 
ocular surface diseases, yet we have thus far found no direct evi-
dence of corneal disease linked to LRIG1. However, we did find 
that the abnormal corneal epithelial differentiation (malignancy) 
leads to the loss of Lrig1 in squamous cell carcinomas of the ocu-
lar surface epithelium (data not shown). The relationship between 
tumorigenesis and the stem cell–related inflammatory pathway is 
difficult to elucidate, and future extensive examination is needed 
to clarify this point.
Figure 9
Model of the function of LRIG1 in corneal homeostasis. (A) In a normal situation (WT), the cornea is self-renewed by Lrig1(+) corneal stem/
progenitor cells after injury. Corneal transparency is maintained via negative regulation of the Stat3-dependent inflammatory pathway by LRIG1. 
(B) Loss of Lrig1 (KO) causes the proinflammatory state in Lrig1 (–) corneal stem/progenitor cells, and impairs wound-induced stem cell replace-
ment (delayed/incomplete wound healing). Loss of Lrig1 activates the Stat3-dependent inflammatory pathway and induces chronic inflammation, 
resulting in remodeling of the corneal stroma. Inductive BM-derived cells secrete inflammatory cytokines and cause the cell-fate changes to 
keratinized epithelium. Epi, corneal epithelium; S, corneal stroma; End, corneal endothelium; NV, neovascularization.
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tion as the primary antibody, and the primary antibody for the respective 
specimen was omitted. The sections were then incubated with appropriate 
secondary antibodies at RT for 1 hour. After being washed 3 times with 
PBS, the sections were then mounted using glycerol containing propidium 
iodide (PI) or DAPI (Vectashield; Vector Laboratories Inc.), and examined 
under a confocal microscope (Fluoview; Olympus Corp.).
Electron microscopy. Following our previous protocol (45), whole eyes were 
examined by transmission electron microscopy (TEM). Specimens were fixed 
in 2.5% glutaraldehyde in 0.1 M PBS, washed 3 times for 15 minutes in PBS, 
and post-fixed for 2 hours in 2% aqueous osmium tetroxide. They were then 
washed 3 more times in PBS before being passed through a graded ethanol 
series. For TEM preparation, the specimens were embedded in Agar 100-
epoxy resin (Agar Scientific). Ultrathin (70 nm) sections were collected on 
copper grids and stained for 1 hour each with uranyl acetate and 1% phos-
photungstic acid, and then for 20 minutes with Reynold’s lead citrate prior to 
examination on a transmission electron microscope (JEM 1010; JEOL Ltd.).
Real-time PCR. Since the mouse cornea is very small, we optimized the 
conditions to improve the quality and accuracy of this experiment. We 
found that pooling 4 corneas was the minimum required to perform quan-
titative PCRs. The efficacy of each primer set used was also checked before 
the experiments were performed. All samples were homogenized in RLT 
lysis buffer (QIAGEN), and total RNA was eluted using the RNeasy Mini 
Kit (QIAGEN) according to the manufacturer’s recommendations. After 
reverse transcription and cDNA synthesis, the relative abundance of tran-
scripts was detected by SYBR Green PCR Master Mix (Applied Biosystems) 
according to the manufacturer’s instructions. The average value of dupli-
cates from each transcript was used for comparison, and the expression 
levels of the individual transcripts were normalized by the expression level 
of β-actin. The primers that were used are shown in Supplemental Table 3.
BrdU labeling. According to the manufacturer’s protocol (Zymed Labora-
tories Inc.), we injected the Lrig1 mice (n = 3) and cultured corneal epithelial 
cells on amniotic membrane with BrdU-labeling reagent (1 ml/100 g). After 
2 hours, the mice were sacrificed, and the eye and cultured cells were then 
embedded in Tissue-Tek II OCT compound (Sakura Finetek Europe B.V.).
3D culture. Mouse corneal epithelial cells were cultured according to our 
previously reported system (43–46). Corneal epithelial explants, including 
the corneal limbus (n = 3), were put onto denuded amniotic membrane 
substrate spread on the bottom of culture inserts and cocultured for 
14 days with mitomycin C–inactivated 3T3 fibroblasts (2 × 104 cells/cm2). 
The culture medium consisted of a defined keratinocyte growth medium 
(KGM) (Gibco; Life Technologies) supplemented with 5% FBS. The cul-
tures were incubated at 37°C in a 5% CO2–95% air incubator, and the 
medium was changed daily.
In vivo wound model. Experimental mice (Lrig1 WT and Lrig1-KO, 8 weeks 
old, n = 4 each) were anesthetized by intraperitoneal injection of combined 
xylazine and ketamine. After an administration of topical oxybuprocaine 
eye drops (Santen Pharmaceutical Co.), central corneal epithelial debride-
ment was performed, using a commercially available hand-held diamond-
tipped glass engraver (IH-640; Ito Co.), under a stereomicroscope. Briefly, 
we used a 2-mm trephine to demarcate the margins of the wound (both 
single and repeated wounds) to avoid damaging the peripheral cornea 
and limbal areas. To perform the repeated wound, we first used fluores-
cein green staining to identify areas of intact epithelial tissue. If there was 
intact epithelium within the 2-mm demarked area, it was removed with 
the hand-held diamond-tipped glass engraver. At this point, we paid care-
ful attention to avoid damaging the corneal stroma as much as possible. 
The experimental mice were killed by an overdose of sodium pentobarbital, 
and the eyes were then enucleated and embedded in OCT compound. To 
observe the area of remaining epithelial defect at the different time points, 
fluorescein green staining was used.
Methods
Mice. Lrig1-KO mice were regenerated from cryopreserved sperm (C57BL/6 
background) (13). Genotyping was performed using 3 different primers 
(Supplemental Table 2; WT: 322 bp, KO: 400 bp). The K5 Stat3 Tg mice 
were as described previously (26). Mice were born with the expected ratio of 
Mendelian inheritance, and no changes in sex ratios were observed.
Tissues. All human cornea tissues were obtained from SightLife Eye 
Bank, and all corneas were stored at 4°C in storage medium (Optisol-
GS; Bausch & Lomb).
Antibodies. For immunohistochemistry, the following antibodies were 
used: mouse mAb anti–β-catenin (610153, ×200; BD Biosciences), rat mAbs 
anti-BrdU (ab6326, ×200; Abcam Plc), anti-CD31 (550274, ×200; BD Biosci-
ences), anti-F4/80 (RM2900, ×100; Life Technologies), anti-GR1 (553128, 
×100; BD Biosciences), and anti-CD3 (MAB4841, ×100; R&D Systems, 
Inc.), rabbit polyclonal antibodies (pAbs) anti-LRIG1 (×200; provided by S. 
Itami, Osaka University), anti-loricrin (PRB-145P, ×700; COVANCE), anti–
keratin 12 (KR074, ×200; Transgenic), anti-Stat3 (9132, ×200; Cell Signaling 
Technology), anti–phospho-Stat3 (9131, ×200; Cell Signaling Technology), 
anti–phospho-EGFR (ab40815, ×200; Abcam), and anti–c-Met (sc-162, ×50; 
Santa Cruz Biotechnology, Inc.), goat pAbs anti-LRIG1 (sc-50076, ×200; 
Santa Cruz Biotechnology), anti-EGFR (E1282, ×100; Sigma-Aldrich), and 
anti-Notch1 (sc-6014, ×50; Santa Cruz Biotechnology Inc.). Secondary 
antibodies included Alexa Fluor 488 anti-mouse, rat, rabbit, and goat IgG 
(×1500), and Alexa Fluor 594 anti-rat IgG (×1500) (Molecular Probes). Anti-
bodies used for cell surface staining were phycoerythrin-conjugated αCD8 
(53-6.7), fluorescein isothiocyanate–conjugated αF4/80 (BM8) and αCD4 
(RM4-5), allophycocyanin-conjugated αCD19 (1D3), PeCy7-conjugated 
αIgM (II/41), and αCD11b (M1/70) (eBioscience Inc.).
Clonal analysis. For clonal analysis, we applied the method of Barrandon 
and Green (11). Secondary cultures of human corneal epithelial cells were 
used. Briefly, single cells isolated under an inverted microscope were inoc-
ulated into 12-well plates that contained a feeder layer of mitomycin C– 
inactivated NIH-3T3 fibroblasts. After 7 days, a single clone was identi-
fied under an inverted microscope and then photographed. Each clone was 
then divided into 2 parts; 3/4 of the clone was used for DNA chip assay, 
and the other 1/4 of the clone was transferred to an indicator dish, fixed 10 
to 12 days later, and stained with 0.1% toluidine blue for classification of 
the clonal type, which was determined by the percentage of aborted colo-
nies (11, 43). When 0% to 5% of the colonies became terminal, the clone 
was classified as a holoclone. When all colonies were terminal or when no 
colonies formed, the clone was classified as a paraclone.
Gene expression analysis. Gene expression profiles were examined by use of 
a high-density oligonucleotide probe array, GeneChip, of Human Genome 
U133 Plus 2.0 (Affymetrix). Total RNA was extracted using the RNeasy kit 
(QIAGEN). cRNA preparation and target hybridization were performed 
according to the Affymetrix GeneChip technical protocol. The DNA chips 
were scanned with a specially designed confocal scanner (GeneChip Scan-
ner 3000; Affymetrix). Array data analysis was performed with Affymetrix 
GeneChip Operating Software (GCOS) version 1.0. The full list of normal-
ized human DNA chip data is presented in Supplemental Table 2.
Immunohistochemistry. Immunohistochemical studies followed our previ-
ously described method (43, 44). Briefly, 8-μm–thick sections were placed 
on silane-coated slides, air dried, and then fixed in 100% acetone or 4% 
paraformaldehyde at 4°C for 15 minutes. After washing in PBS at room 
temperature (RT) for 15 minutes, sections were incubated with 1% BSA 
(Sigma-Aldrich Corporation) at RT for 30 minutes to block nonspecific 
binding. Sections were then incubated with primary antibody at RT for 
1 hour and washed 3 times in PBS containing 0.15% TRITON X-100 (Dow 
Chemical Company) for 15 minutes. Control incubations were with the 
appropriate normal mouse, rat, rabbit, and goat IgG at the same concentra-
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0.01 were considered significant. The values are presented as mean ± SD. 
FACS data were analyzed with FlowJo software (TreeStar Inc.) and Graph-
Pad Prism software (GraphPad Software Inc.). Statistical significance was 
determined using a 2-tailed Mann-Whitney U test for paired samples or 
1-way ANOVA and nonparametric tests for multiple groups. P < 0.05 was 
considered statistically significant.
Study approval. All animals used for this study were maintained and 
handled according to the protocols approved by the Kyoto Prefectural 
University of Medicine. All animal studies were approved by the Commit-
tee on Animal Research of Kyoto Prefectural University of Medicine. All 
experiments were performed in accordance with the tenets set forth in the 
Declaration of Helsinki.
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Luciferase promoter assay. Transfection of luciferase reporters into cul-
tured Lrig1 WT and Lrig1-KO mice conjunctival fibroblasts and keratino-
cytes followed our previous protocol (47). Both fibroblasts and keratino-
cytes were plated in 24-well culture plates and cultured in DMEM with 
10% FBS (fibroblast) or defined KGM (keratinocyte) for 18 to 24 hours 
before transfection. A Stat3 Reporter Assay Kit (QIAGEN) was used to 
measure the transcription factor activity. Cells (3 × 104) were cotransfected 
by Lipofectamine (fibroblast; Life Technologies) or FuGENE HD (kera-
tinocyte; Promega) for 24 hours, followed by cytokine treatment (IL-6; 
BioLegend Inc.) for 6 hours. The resultant cells were lysed with 100 μl 
Passive Lysis Buffer (Promega). Luciferase activity was read on a Veritas 
Microplate Luminometer (Promega).
Generation of BM chimera mice. BM chimera mice were generated with 
5 × 106 freshly isolated total BM cells from the femur and tibia of Lrig1 
WT or Lrig1-KO mice (donor, 10–12 weeks), respectively, following our 
previous protocol (48, 49). Isolated cells were intravenously injected either 
into lethally irradiated (900 cGY) Lrig1 WT or Lrig1-KO mice (host, 16–18 
weeks). A mechanical corneal wound was applied to the hosts 10 weeks 
after BM reconstitution. The efficiency of corneal wound healing and 
hematopoietic reconstitution of lymphoid organs of the hosts by donor-
derived cells was assessed 13 weeks after BM transfer by genotyping tail, 
thymus, and BM DNA. Furthermore, lymphoid organs of reconstituted 
mice were analyzed by FACS as described below and were compared in sta-
tistical analysis to those of age-matched Lrig1 WT or Lrig1-KO mice.
Flow cytometric analysis. Single-cell suspensions of freshly isolated thy-
mus, spleen, and total BM cells of the femur and tibia were subsequently 
incubated with αCD16/CD32 for 10 minutes, followed by staining with 
a combination of conjugated antibodies in FACS buffer (PBS + 4% heat-
inactivated FCS + 2 mM EDTA) for 30 minutes. Stained cells were analyzed 
on a FACSCanto II flow cytometer (BD Biosciences).
Statistics. The 2-tailed, unpaired Student’s t test was used to compare the 
differences between 2 groups, and P values of less than 0.05 or less than 
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